Taurus review

The dedicated NAD+, sermorelin and glutathione pages explicitly call $79 the first-month price. They also display $179, but that comparison figure does not establish the selected renewal charge. June 2025 terms separately describe a recurring $17.99 healthcare membership per billing period unless purchase terms state otherwise. The period length and whether that fee is additional to a specific peptide offer are not established. Ask for the medication price, membership treatment, billing interval, shipping charge and supply covered by each payment. Do not treat either $79 or $96.99 as a verified recurring monthly total without that agreement.

NAD+ and glutathione pages display 200 mg/mL and a 5 mL bottle, while the sermorelin page prints 2 mcg/mL and a 5 mL bottle. Each advertises a home kit. The sermorelin unit should be clarified with the actual prescriber and pharmacy rather than silently changed to mg/mL. These are seller descriptions, not an instruction to calculate or administer a dose. Per-shot marketing figures do not establish the prescribed injection count, kit contents, supply duration or selected invoice. Obtain the actual label, concentration and administration instructions for the medication dispensed to you.

The terms identify Taurus Medical, Inc. as the platform and OpenLoop Health, Inc. as partner MSO. They also name RedRock Pharmacy in Utah, Health Warehouse in Kentucky, Precision Compounding Pharmacy in New York and Triad Rx in Alabama. OpenLoop’s public consent describes multiple professional entities and says the treating practice must be identified at the visit. None of those disclosures assigns your clinician or dispenser in advance. A partner name also does not independently verify current licensure, facility category or availability of a particular formulation. Ask for the treating practice and the actual dispensing-pharmacy details for your prescription.

The free baseline testosterone test is advertised for TRT, so it should not be counted as a peptide laboratory benefit. The general policy describes services that may include consultations, labs and 24/7 patient support, but also says inclusions vary. It does not establish a funded peptide panel, repeat-test allowance, fixed live-visit schedule or continuous clinician availability. General terms set an age minimum of 18. The legal disclosures in OpenLoop’s consent are not a Taurus product coverage map. Confirm your physical-state eligibility, the selected treatment and the cost of any required testing before relying on a broad service description.

The February 2026 policy requires a cancellation request at least 72 hours before billing through the customer-service or account process. A late request can result in another charge, with cancellation taking effect for the following cycle. General terms describe access through the paid period. Initial medical disqualification is described as qualifying for a full refund, but later disqualification language limits refunds to the most recent cycle and accounts for services already rendered. Ordinary voluntary cancellation is nonrefundable; shipped medication is final and paid blood tests are nonrefundable once submitted. Keep the selected agreement and a dated cancellation confirmation.

The policy describes evidence-based replacement for damage and replacement for an incorrect medication, with prompt reporting to support. It does not establish a universal cash refund, numeric reporting deadline, delivery fee or temperature-excursion remedy for every peptide offer. Do not use unclear or damaged medication while waiting for instructions from the actual clinician or pharmacy. The homepage retains broad FDA-approved-medication wording, but dedicated product pages carry compounded-medication and nonapproval disclosures. A compounded preparation is not an FDA-approved finished drug, and seller recovery, anti-aging or hormone outcome claims are not proof of your results or a product’s safety and effectiveness.